Dorsal horn inhibitory interneuron

Dorsal horn inhibitory interneurons are a diverse group of neurons located within the dorsal horn region of the spinal cord. They primarily use gamma-Aminobutyric acid (GABA) and/or glycine as neurotransmitters. These cells play a critical role in modulating incoming somatosensory signals—including those related to touch, temperature, pain, and itch—by providing both presynaptic inhibition at primary afferent terminals and postsynaptic inhibition within local microcircuits. This gating function is essential for preventing overexcitation that can lead to chronic pain states such as allodynia or pruritus. Dysfunction or loss of these neurons has been directly linked with pathological conditions where innocuous stimuli become painful ("disinhibition" hypothesis). Molecular classification schemes have identified several non-overlapping populations based on expression profiles including NPY+, parvalbumin+, nNOS+, dynorphin/galanin+, among others. While not a single molecular target but rather a functional cell type comprising multiple molecular identities, they represent an emerging therapeutic focus for novel analgesics aimed at restoring proper sensory gating without global nervous system depression[3][4][5][6][7].

Other names

Inhibitory interneuron of the dorsal hornSpinal dorsal horn inhibitory interneuronSDH inhibitory interneuronGABAergic/glycinergic dorsal horn neuron (for specific subtypes)

Enhancement or restoration of inhibitory neurotransmission reduces pathological pain and itch behaviors. For example, chemogenetic activation or optogenetic stimulation can suppress hypersensitivity in animal models. Loss or silencing leads to disinhibition and increased sensitivity to normally innocuous stimuli.